Literature DB >> 72115

Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2.

P S Morahan, M C Breinig, M B McGeorge.   

Abstract

The temporal relationships among the humoral and cellular immune responses were defined in BALB/c mice after vaginal or systemic infection with herpes simplex virus type 2 (HSV-2). After vaginal infection, mice showed evidence of clinical vaginitis on days 4 to 6 and HSV-2 replication was detected locally in the vaginal secretions, cervix, vagina, and uterus before the virus subsequently spread to the central nervous system. Death from encephalitis occurred between 7 and 10 days after infection. Vaginal infection was associated with significant delayed type hypersensitivity and splenic proliferative cell-mediated immune responses which appeared during the acute infection and waned by 3 weeks. There was almost no evidence of a systemic neutralizing antibody response at any time after vaginal infection. In contrast to the local vaginal infection, systemic i.v. HSV-2 infection induced a humoral response as well as the two cellular immune responses. Although both cellular immune responses appeared during the acute infection (days 6 to 14) and persisted for approximately 5 weeks, the humoral response appeared in surviving animals and persisted for at least 4 months. Thus, vaginal HSV-2 infection was associated primarily with transient cellular immune responses, whereas i.v. HSV-2 infection induced prolonged systemic humoral and cellular immune responses.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72115

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Comparison of various macrophage-inhibitory agents on vaginal and systemic herpes simplex virus type 2 infections.

Authors:  M B McGeorge; P S Morahan
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

2.  Immunity to herpes simplex virus type 2: recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors.

Authors:  T Iwasaka; J F Sheridan; L Aurelian
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

3.  The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice.

Authors:  K E Schneweis; J Gruber; J Hilfenhaus; A Möslein; M Kayser; M H Wolff
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

4.  Kinetics and genetics of herpes simplex virus-induced antibody formation in mice.

Authors:  A Knoblich; J Görtz; V Härle-Grupp; D Falke
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1.

Authors:  P S Morahan; T A Thomson; S Kohl; B K Murray
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

6.  Virus spread and initial pathological changes in the nervous system in genital herpes simplex virus type 2 infection in mice. A correlative immunohistochemical, light and electron microscopic study.

Authors:  G Georgsson; J R Martin; G L Stoner; H F Webster
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

7.  Autonomic nervous system involvement in experimental genital infection by herpes simplex virus type 2.

Authors:  N A Sanjuan; E F Lascano
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus.

Authors:  P S Morahan; P C Klykken; S H Smith; L S Harris; A E Munson
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

9.  Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2.

Authors:  M R McDermott; J R Smiley; P Leslie; J Brais; H E Rudzroga; J Bienenstock
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

10.  Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice.

Authors:  L R Crane; D A Milne; J C Sunstrum; A M Lerner
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.